about
Alexander diseaseGenetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survivalType 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.Alexander's disease: reassessment of a neonatal form.Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease.Neurological diseases as primary gliopathies: a reassessment of neurocentrismAstrogliopathology in neurological, neurodevelopmental and psychiatric disorders.CSF and Blood Levels of GFAP in Alexander DiseaseProtein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryGFAP expression as an indicator of disease severity in mouse models of Alexander disease.Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes.The Evolving View of AstrocytesThe protective and therapeutic function of small heat shock proteins in neurological diseases.Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.Juvenile alexander disease: a case report.Stem cell therapy for white matter disorders: don't forget the microenvironment!Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.Follow-up study of 22 Chinese children with Alexander disease and analysis of parental origin of de novo GFAP mutations.Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease.
P2860
Q24633313-FCBAAC3F-5931-4494-AE23-CF1036B63DD6Q28385079-8CAE5942-102F-44F2-AE0F-025C7B0D5957Q34259303-9D8D64BF-5097-4ADC-8775-11A038856C6AQ34293888-911BDD20-311B-4856-94E8-1A8D3ED0F534Q35778386-99B53A69-7F85-4F18-B372-5D5434535F43Q35872654-F2B2BC20-93DA-493F-89BA-DF62727AE532Q36118835-876B640C-0404-4AE8-9955-66CEB78DB4E4Q36154360-B55E7716-481C-4DCA-BBB7-D9085C6D6656Q36599253-2594667D-AF9E-4649-8C9C-C977753DDF89Q36706156-89FB5601-75A7-4A14-9975-5404CC3BE163Q37084919-0F0BD612-E22A-444B-A558-E9A0B757C8B8Q37543857-2B402D4A-B3F0-47AB-A70E-9EE5D9B084F5Q38008372-7CBD1050-A5B7-4845-BEE1-0A3CCC7EBC7BQ38480577-139E3F83-89C4-4CC6-B24E-D769389BF3BBQ38754750-5755D259-5DB6-4969-A46C-22A60D08D58FQ41819672-580F856C-DBA6-4FCF-8F31-BF32DD93409EQ42009902-422BD3AE-9420-4E87-8AFE-13172A88A80FQ43435870-6C6433C9-B12E-4946-8CB8-30488790DA2CQ44759892-F340C42C-F4AD-48A8-B6DA-66ADCE68DC08Q47308800-6E645176-C988-4568-83CC-59AE1CE738D1
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Strategies for treatment in Alexander disease
@ast
Strategies for treatment in Alexander disease
@en
Strategies for treatment in Alexander disease
@nl
type
label
Strategies for treatment in Alexander disease
@ast
Strategies for treatment in Alexander disease
@en
Strategies for treatment in Alexander disease
@nl
prefLabel
Strategies for treatment in Alexander disease
@ast
Strategies for treatment in Alexander disease
@en
Strategies for treatment in Alexander disease
@nl
P2093
P2860
P3181
P1433
P1476
Strategies for treatment in Alexander disease
@en
P2093
Albee Messing
Christine M LaPash Daniels
Tracy L Hagemann
P2860
P2888
P304
P3181
P356
10.1016/J.NURT.2010.05.013
P407
P577
2010-10-01T00:00:00Z
P5875
P6179
1024182083